Form 4: Zimmer Biomet Exec's RSU Vesting & New Grant

Zimmer Biomet's Group President, EMEA, Wilfred Van Zuilen, reported the vesting of restricted stock units, subsequent tax withholding, and a new RSU grant.

Summary

• Wilfred Van Zuilen, Group President, EMEA, of Zimmer Biomet Holdings, Inc. (ZBH), reported transactions on February 20, 2026.
• 2,451 Restricted Stock Units (RSUs) vested and converted into common stock.
• 638 shares of common stock were withheld by the company at $98.62 per share to cover tax obligations related to the RSU vesting.
• A new grant of 10,334 Restricted Stock Units was issued, which will vest annually over three years, commencing February 20, 2027.
• Following these transactions, beneficial ownership of common stock decreased to 23,455 shares.
• Beneficial ownership of derivative securities (RSUs) includes 2,450 units remaining from previous grants and the newly granted 10,334 units.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a slightly positive event, reflecting routine executive compensation and continued alignment of executive incentives with the company's long-term performance through a new RSU grant.

Positives

• Grant of 10,334 new Restricted Stock Units, demonstrating continued long-term incentive for the executive.
• Vesting of 2,451 Restricted Stock Units, converting contingent rights into actual common stock.

Negatives

• 638 shares of common stock were disposed of to satisfy tax withholding obligations, reducing direct common stock ownership.

Future Outlook

The newly granted 10,334 Restricted Stock Units will vest annually over three years, with the first tranche vesting on February 20, 2027, indicating a continued long-term incentive structure for the executive.

Industry Context

StockSavvy.ai notes that routine executive compensation events, such as RSU vesting and new grants, are standard practice across the medical device industry to align executive incentives with long-term shareholder value. This filing reflects a typical compensation structure for a senior executive at a major player like Zimmer Biomet.

Stakeholder Impact

• Shareholders: The RSU grant aligns executive incentives with shareholder interests over the long term. The tax withholding slightly reduces the executive's direct common stock ownership.
• Employees: This filing pertains to a specific executive's compensation and does not directly impact the broader employee base, though it reflects the company's executive compensation philosophy.

Next Steps

• Annual vesting of the 10,334 Restricted Stock Units will commence on February 20, 2027, and continue over three years.

Key Dates

Keywords

Zimmer Biomet, ZBH, Form 4, Insider Transaction, Restricted Stock Units, RSU, Executive Compensation, Stock Vesting, Tax Withholding, Wilfred Van Zuilen